Knowledge about Cervical Cancer, Health Beliefs and Human Papillomavirus Vaccination Rate in Female University Students

여대생의 자궁경부암 지식, 인유두종바이러스 예방접종 관련 건강신념 및 접종실태

  • 이은주 (계명대학교 대학원 간호학과) ;
  • 박정숙 (계명대학교 간호대학)
  • Received : 2011.01.06
  • Accepted : 2011.01.19
  • Published : 2011.02.28


Purpose: This study was a descriptive study to determine knowledge regarding cervical cancer, health beliefs, and Human Papillomavirus (HPV) vaccination rate of female university students. Methods: The subjects of this study were 777 female university students. The data were collected through interviews using a structured questionnaire from september 1 to October 30, 2010. The data were analysed using descriptive statistics, t-test, ANOVA, and chi-square test. Results: The mean of cervical cancer knowledge was low (13.75 score). Regarding health beliefs about HPV vaccination, the levels of perceived benefit (3.01 score) and seriousness (2.91 score) were relatively high, whereas the levels of perceived barrier (2.09 score) and susceptibility (2.01 score) were relatively low. The rate of HPV vaccination was 5.5%. Conclusion: These results show that concrete educational programs and advertisement are mandated to reduce HPV infection and increase HPV vaccination rate. Also the strategies emphasizing perceived seriousness and benefits of obtaining HPV vaccination are taken into account in developing educational programs in addition to knowledge improvement on HPV and cervical cancer.


  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
  2. National Cancer Information Center. 2006-2007 cancer statistics. Available at: [accessed on 8 June 2010].
  3. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 2005;89:S4-S12.
  4. Dodd LG, Sneige N, Villarreal Y, Fanning CV, Staerkel GA, Caraway NP, et al. Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies. Diagn Cytopathol 1993;9:138-44.
  5. Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, et al. Cervical cancer. Cancer 2003;98:2009-14.
  6. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
  7. Centers for Disease Control and Prevention. Genital HPV infection. Available at: [accessed on 8 July 2010].
  8. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O, Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low-and high-grade lesions. Am J Surg Pathol 1992;16:641-9.
  9. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.<12::AID-PATH431>3.0.CO;2-F
  10. Munoz N, Bosch FX, Castellsague X, Díaz M, de Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-85.
  11. Choi KA, Kim JH, Lee KS, Oh JK, Liu SN, Shin HR. Knowledge of human papillomavirus infection and acceptability of vaccination among adult women in Korea. Korean J Obstet Gynecol 2008;51:617-23.
  12. Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004;96:604-15.
  13. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in Young Women. N Engl J Med 1998;338:423-8.
  14. Shin HR, Franceschi S, Vaccarella S, Roh JW, Ju YH, Oh JK, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004;190:468-76.
  15. Hoque ME. Cervical cancer awareness and preventive behaviour among female university students in South Africa. Asian Pac J Cancer Prev 2010; 11:127-30.
  16. Lenselink CH, Schmeink CE, Melchers WJ, Massuger LF, Hendriks JC, van Hamont D, et al. Young adults and acceptance of the human papillomavirus vaccine. Public Health 2008;122:1295-301.
  17. Wong LP, Sam IC. Ethnically diverse female university students' knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol 2010;148: 90-5.
  18. Kim JH, Park MK. Study on the knowledge of cervical cancer and human papillomavirus and preventive behavior intention of female university students. J Korean Acad Soc Nurs Educ 2009;15:225-31.
  19. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10-15 year old adolescents. J Low Genit Tract Dis 2004;8:188-94.
  20. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human pa-pillomavirus vaccine in young women. Int J STD AIDS 2003;154:300-6.
  21. Zimet GD, Fortenberry JD, Fife KH, Tyring SK, Herne K, Douglas JM.Acceptability of genital herpes immunization. The role of health belief and health behaviors. Sex Transm Dis 1997;24:555-60.
  22. Castellsague X, Schneider A, Kaufmann AM, Bosch FX. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 2009;115 3 Suppl:S15 -23.
  23. Kim HW, Ahn HY. Study on the knowledge of human papilloma virus in female university students. Korean J Women Health Nurs 2007;13: 13-20.
  24. Lee SH. Relationship between knowledge level and cancer-prevention performance in anti-cancer vaccine of human papilloma virus (HPV) and cervical cancer in women [master's thesis]. Seoul: Ewha Womans Univ;2009.
  25. Han YJ, Lee SR, Kang EJ, Kim MK, Kim NH, Kim HJ, et al. Knowledge regarding cervical cancer, human papillomavirus and future acceptance of vaccination among girls in their Late teens in Korea. Int J Obstet Gynaecol 2007;50:1090-9.
  26. Daley EM, Vamos CA, Buhi ER, Kolar SK, McDermott RJ, Hernandez, et al. Influences on human papillomavirus vaccination status among female college students. J Womens Health (Larchmt) 2010;19:1885-91.
  27. Medscape. Quadrivalent HPV vaccine (Gardasil) cuts rates of genital warts. Available at: [accessed on 18 July 2010].
  28. Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005;37: 248-51.
  29. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez-Avila M, Munoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001;32:243-7.
  30. Bakogianni GD, Nikolakopoulos KM, Nikolakopoulou NM. HPV vaccine acceptance among female Greek students. Int J Adolesc Med Health 2010;22:271-3.